Eye Drops for Dry AMD (Geographic Atrophy Treatment Evaluation, GATE): Alcon


Description: Alcon is conducting a Phase II/III clinical trial of an eye drop known as AL-8309B for the treatment of advanced dry age-related macular degeneration (geographic atrophy). Outcomes being measured are lesion growth and visual acuity. Approximately 550 participants are enrolled in the two-year study.

Trial Status: Ongoing; not recruiting.

Additional Information:
Alcon’s AL-8309B eye drops for dry AMD clinical trial listing on ClinicalTrials.gov